American National Bank & Trust Co. VA Invests $3.12 Million in Chemed Co. (NYSE:CHE)

American National Bank & Trust Co. VA acquired a new position in shares of Chemed Co. (NYSE:CHE) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,864 shares of the company’s stock, valued at approximately $3,122,000.

Other large investors also recently made changes to their positions in the company. Rise Advisors LLC bought a new stake in shares of Chemed during the first quarter worth $26,000. GAMMA Investing LLC acquired a new position in Chemed during the fourth quarter worth $37,000. Principal Securities Inc. acquired a new position in Chemed during the fourth quarter worth $51,000. SRS Capital Advisors Inc. boosted its holdings in Chemed by 110.6% during the fourth quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock worth $58,000 after purchasing an additional 52 shares during the last quarter. Finally, Mather Group LLC. acquired a new position in Chemed during the first quarter worth $67,000. Institutional investors own 95.85% of the company’s stock.

Chemed Price Performance

CHE stock traded down $1.68 during trading hours on Thursday, reaching $540.00. The stock had a trading volume of 76,198 shares, compared to its average volume of 93,278. The stock has a market capitalization of $8.18 billion, a PE ratio of 29.06, a price-to-earnings-growth ratio of 2.23 and a beta of 0.43. The stock has a 50-day simple moving average of $552.98 and a 200 day simple moving average of $588.21. Chemed Co. has a fifty-two week low of $492.84 and a fifty-two week high of $654.62.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Wednesday, April 24th. The company reported $4.68 EPS for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). The firm had revenue of $589.23 million during the quarter, compared to analyst estimates of $587.18 million. Chemed had a net margin of 12.36% and a return on equity of 30.52%. On average, sell-side analysts forecast that Chemed Co. will post 21.54 EPS for the current fiscal year.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 18th. Shareholders of record on Thursday, May 30th were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date was Thursday, May 30th. Chemed’s dividend payout ratio is currently 8.61%.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday, May 4th. Royal Bank of Canada reduced their target price on shares of Chemed from $712.00 to $697.00 and set an “outperform” rating for the company in a report on Tuesday, May 21st.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 1,500 shares of the stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $544.17, for a total value of $816,255.00. Following the completion of the sale, the chief executive officer now owns 107,049 shares in the company, valued at $58,252,854.33. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, CEO Kevin J. Mcnamara sold 4,000 shares of the firm’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the completion of the sale, the chief executive officer now owns 108,549 shares in the company, valued at approximately $61,605,899.46. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 1,500 shares of the firm’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $544.17, for a total transaction of $816,255.00. Following the sale, the chief executive officer now owns 107,049 shares of the company’s stock, valued at approximately $58,252,854.33. The disclosure for this sale can be found here. Insiders sold a total of 5,784 shares of company stock worth $3,240,053 over the last quarter. 3.32% of the stock is currently owned by insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.